Key facts
- Klaimy’s last known valuation is $4.2M (Apr 2025).
- It has raised $1.3M; the latest was Seed Round ($1.3M) in Apr 2025.
- Notable investors include Tenity, Insurtech Gateway, U-investors, WILLA (Paris), platform58.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Klaimy
- ·The full record, as it builds
Funding rounds
No funding rounds for Klaimy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Klaimy
Developer of an artificial intelligence software system designed for processing and analyzing medical and administrative insurance documents. The company's platform extracts and structures unstructured data, verifies document completeness and compliance, performs data validation and preliminary fraud checks using external sources, identifies medical risk factors, and summarizes complex records, enabling insurers and brokers to process insurance-related medical and administrative workflows efficiently.
- Sector
- Information Technology
- HQ
- Paris, France
- Founded
- 2023
- Employees
- 7
- Website
- getklaimy.com/
- Ownership
- Privately Held (backing)
Klaimy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Klaimy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Klaimy in its N-PORT filings yet. We sweep new filings monthly.